CD44 and hepatocellular carcinoma: The HCC-1937 cell line was chosen as a negative control since it is also derived from breast malignant tissue but, when grown as a xenograft and unlike MDA-MB-231, shows no response to anti-CD44 treatment (18% TGI; S8 Fig).